View in EDS

International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set.

Saved in:
Bibliographic Details
Title: International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set.
Authors: Samuel R; NIHR Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; University of Leeds, Leeds Institute for Medical Research, St. James's University Hospital, Leeds, UK., Knight SR; Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK.; School of Health and Wellbeing, University of Glasgow, Glasgow, UK., Adams R; Centre for Trials Research, Cardiff University School of Medicine, Cardiff, UK., Das P; University of Texas MD Anderson Cancer Center, USA., Dorth J; Department of Radiation Oncology, University Hospitals Cleveland Medical Centre, Cleveland, USA., Finch D; NIHR Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; Colorectal and Peritoneal Oncology Centre, The Christie NHS FT, Manchester., Guren MG; Department of Oncology, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Hawkins MA; Department of Medical Physics and Biomedical Engineering, University College London, London, UK., Moug S; Department of Colorectal Surgery, Royal Alexandra Hospital, Paisley, UK., Rajdev L; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Sebag-Montefiore D; University of Leeds, Leeds Institute for Medical Research, St. James's University Hospital, Leeds, UK., Renehan AG; NIHR Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; Colorectal and Peritoneal Oncology Centre, The Christie NHS FT, Manchester., Fish R; NIHR Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; Colorectal and Peritoneal Oncology Centre, The Christie NHS FT, Manchester.
Corporate Authors: plus the CORMAC-2 collaborators
Source: EClinicalMedicine [EClinicalMedicine] 2024 Dec 05; Vol. 78, pp. 102939. Date of Electronic Publication: 2024 Dec 05 (Print Publication: 2024).
Publication Type: Journal Article; Review
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39720423
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Samuel+R%22">Samuel R</searchLink>; NIHR Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; University of Leeds, Leeds Institute for Medical Research, St. James's University Hospital, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Knight+SR%22">Knight SR</searchLink>; Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK.; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Adams+R%22">Adams R</searchLink>; Centre for Trials Research, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Das+P%22">Das P</searchLink>; University of Texas MD Anderson Cancer Center, USA.<br /><searchLink fieldCode="AU" term="%22Dorth+J%22">Dorth J</searchLink>; Department of Radiation Oncology, University Hospitals Cleveland Medical Centre, Cleveland, USA.<br /><searchLink fieldCode="AU" term="%22Finch+D%22">Finch D</searchLink>; NIHR Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; Colorectal and Peritoneal Oncology Centre, The Christie NHS FT, Manchester.<br /><searchLink fieldCode="AU" term="%22Guren+MG%22">Guren MG</searchLink>; Department of Oncology, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Hawkins+MA%22">Hawkins MA</searchLink>; Department of Medical Physics and Biomedical Engineering, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Moug+S%22">Moug S</searchLink>; Department of Colorectal Surgery, Royal Alexandra Hospital, Paisley, UK.<br /><searchLink fieldCode="AU" term="%22Rajdev+L%22">Rajdev L</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sebag-Montefiore+D%22">Sebag-Montefiore D</searchLink>; University of Leeds, Leeds Institute for Medical Research, St. James's University Hospital, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Renehan+AG%22">Renehan AG</searchLink>; NIHR Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; Colorectal and Peritoneal Oncology Centre, The Christie NHS FT, Manchester.<br /><searchLink fieldCode="AU" term="%22Fish+R%22">Fish R</searchLink>; NIHR Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; Colorectal and Peritoneal Oncology Centre, The Christie NHS FT, Manchester.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22plus+the+CORMAC-2+collaborators%22">plus the CORMAC-2 collaborators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101733727%22">EClinicalMedicine</searchLink> [EClinicalMedicine] 2024 Dec 05; Vol. 78, pp. 102939. <i>Date of Electronic Publication: </i>2024 Dec 05 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22The+Lancet%22">The Lancet </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101733727 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-5370 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225895370%22">25895370 </searchLink><i>NLM ISO Abbreviation: </i>EClinicalMedicine <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39720423
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.eclinm.2024.102939
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102939
    Titles:
      – TitleFull: International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Samuel R
      – PersonEntity:
          Name:
            NameFull: Knight SR
      – PersonEntity:
          Name:
            NameFull: Adams R
      – PersonEntity:
          Name:
            NameFull: Das P
      – PersonEntity:
          Name:
            NameFull: Dorth J
      – PersonEntity:
          Name:
            NameFull: Finch D
      – PersonEntity:
          Name:
            NameFull: Guren MG
      – PersonEntity:
          Name:
            NameFull: Hawkins MA
      – PersonEntity:
          Name:
            NameFull: Moug S
      – PersonEntity:
          Name:
            NameFull: Rajdev L
      – PersonEntity:
          Name:
            NameFull: Sebag-Montefiore D
      – PersonEntity:
          Name:
            NameFull: Renehan AG
      – PersonEntity:
          Name:
            NameFull: Fish R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 12
              Text: 2024 Dec 05
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2589-5370
          Numbering:
            – Type: volume
              Value: 78
          Titles:
            – TitleFull: EClinicalMedicine
              Type: main
ResultId 1